Skip to main content
Home
  • Solutions
    Clinical solutions
    Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions
    Consulting & Commercial
    Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data
    meeting
    Case studies

    Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

    Innovative research tools showcase
    Technologies

    Technology solutions from early phase through to post-marketing.

  • Sectors
    Sectors

    ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read more
    Biotech Government and Public Health Medical Device Pharmaceuticals
    Biotechnology services navigation panel
    Biotech

    Developing transformative therapies requires a flexible approach.

    Employee engagement program overview
    ICON and You

    Partners making a difference.

  • Therapeutics
    Therapeutics
    Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology
    Cross-therapeutics
    Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health
    Oncology whitepaper web assets
    Oncology

    An early pioneer in oncology CGT, ICON has contributed to over 60 FDA/EMA approved therapies in the last 5 years.

    Biological research visual element
    Therapeutics insights

    ICON's therapeutic experts contribute regularly to industry publications on the latest medical, scientific and clinical developments.

  • Insights
    Insights
    Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel
    whitepaper
    From innovation to implementation: Navigating neurologic monoclonal antibody development

    Strategies for clinical readiness on day one

    thumbnail
    Making sense of the rapidly changing biosimilars landscape

    Strategies for adapting and achieving optimal market access

    thumbnail
    Building a comparative evidence base using network meta-analysis

    Methods, implementation and reporting

  • News & Events
    News & Events

    ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read more
    Press releases In the News Mediakit Awards Events Webinars Social media hub
    Oncology whitepaper web assets
    ASCO 2026

    29 May - 2 June 2026, Booth #35093

    flow cytometry
    Panel discussion: Flow cytometry in bioanalysis

    Watch the webinar.

  • About ICON
    About ICON
    Company history ICON at a glance ICON in Asia Pacific ICON in Latin America Leadership Quality
    ICON for
    Patients Healthy participants Investigators Jobs & Careers Investors Suppliers
    Responsible business practice indicators
    Sustainability, charity, inclusion and belonging

    ICON Cares is our commitment to making a positive impact on our people, environment and our community.

    Modern reception area at Dublin office
    ICON at a glance

    Delivering successful outcomes across the clinical development lifecycle.

  • Careers
  • Investors
  • Contact
  • 日本語
  • 简体中文
  1. Home
  2. Privacy and Data notices
  3. International Transfers

International Transfers

Page tools
Share Share
Facebook

Share on Linkedin

Bluesky

Share on Bluesky

Facebook

Share on X

Facebook

Share on Facebook

Standard Contractual Clauses (“SCCs”) are an approved mechanism for the transfer of personal data from the EEA to a third country (non EEA Country). Their purpose is to ensure that the protections attaching to EEA personal data travels with that data.

SCCs seek to solve gaps between the GDPR and destination countries’ regimes in terms of:

  • Ensuring the personal data is afforded the same level of protection it is in the EEA; and 
  • the rights of the person to whom the data relates e.g. ensuring an EEA individual can exercise their GDPR rights in respect of the data even though the data has left the EEA.

In June 2021 the European Commission published “new SCCs” which take account of the global transfer of data and ensure sufficient safeguards of personal data, in particular taking into account the decision of the EU Court of Justice (CJEU) delivered a ruling in the case known as Schrems II (C-3111/18) (Data Protection Commissioner v Facebook Ireland Ltd and Maximillian Schrems),

For ICON suppliers

In order for ICON and its suppliers to be compliant with its personal data transfer obligations, ICON have selected modules 2 and 3 from the 2021 SCCs template, namely controller to processor and processor to processor, to deal with the scenarios where ICON is the data controller and where ICON is acting as a data processor for a data controller client. ICON has completed the annexes based on its existing arrangements and contracts with suppliers.

ICON has also incorporated reference to Swiss transfers and the UK Data Transfer Agreement Addendum to allow transfers of personal data from UK and Swiss based data subjects as well as EEA data subjects citizens.

By continued engagement with ICON post 27 December 2022, including the provision of services to ICON, you have agreed to be bound and the following agreements (2021 SCCs, including Swiss transfers and the UK Data Transfer Agreement Addendum (“Transfer Agreement”)) are deemed to have been executed by You. The Transfer Agreement is available here.

The Transfer Agreement shall automatically be deemed to be part of any and all contracts, agreements between You (Supplier) and ICON.

If you identify any issue with complying with the Transfer Agreement please reach out to us. 

Contact Us

Connect with us

  • Contact us
  • Submit proposal request
  • Update Email Preferences
  • Global office locator
  • ICON on social media
Site Branding
    ICON plc
  • Contact
  • About ICON
  • Results & Reports
For Clients
  • Therapeutics
  • Solutions
  • Insights
  • Technologies
  • Office locations
ICON for
  • Patients
  • Volunteers
  • Investigators
  • Jobs & Careers
  • Investors
  • Suppliers
News & Events
  • Press releases
  • Mediakit
  • Events
  • Webinars
  • Social media hub
Socials
  • LinkedIn
  • Facebook
  • Instagram
  • YouTube

Legal Footer

  • © 2026 ICON plc
  • Disclaimer
  • Privacy & Data
  • Cookies
  • Sitemap